KNSA logo

Kiniksa Pharmaceuticals (KNSA) Shareholders Equity

Annual Shareholders Equity

$438.44 M
-$403.00 K-0.09%

December 31, 2024


Summary


Performance

KNSA Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKNSAbalance sheetmetrics:

Quarterly Shareholders Equity

$438.44 M
+$1.43 M+0.33%

December 31, 2024


Summary


Performance

KNSA Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKNSAbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

KNSA Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-0.1%0.0%
3 y3 years+136.9%+136.9%
5 y5 years+94.5%+94.5%

KNSA Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-0.1%+136.9%-0.1%+185.6%
5 y5-year-0.1%+136.9%-0.1%+185.6%
alltimeall time-0.1%+588.7%-0.1%+588.7%

Kiniksa Pharmaceuticals Shareholders Equity History

DateAnnualQuarterly
Dec 2024
$438.44 M(-0.1%)
$438.44 M(+0.3%)
Sep 2024
-
$437.01 M(+0.4%)
Jun 2024
-
$435.10 M(+0.7%)
Mar 2024
-
$431.89 M(-1.6%)
Dec 2023
$438.84 M(+10.8%)
$438.84 M(+8.3%)
Sep 2023
-
$405.13 M(-1.6%)
Jun 2023
-
$411.66 M(+5.5%)
Mar 2023
-
$390.10 M(-1.5%)
Dec 2022
$396.15 M(+114.1%)
$396.15 M(+3.2%)
Sep 2022
-
$384.01 M(+150.2%)
Jun 2022
-
$153.49 M(-7.7%)
Mar 2022
-
$166.24 M(-10.2%)
Dec 2021
$185.04 M
$185.04 M(-13.6%)
Sep 2021
-
$214.05 M(-9.2%)
Jun 2021
-
$235.78 M(-12.9%)
DateAnnualQuarterly
Mar 2021
-
$270.70 M(-13.2%)
Dec 2020
$311.94 M(+38.4%)
$311.94 M(-13.0%)
Sep 2020
-
$358.51 M(+43.2%)
Jun 2020
-
$250.42 M(+21.7%)
Mar 2020
-
$205.83 M(-8.7%)
Dec 2019
$225.42 M(-19.3%)
$225.42 M(-10.5%)
Sep 2019
-
$251.91 M(-8.5%)
Jun 2019
-
$275.20 M(-10.2%)
Mar 2019
-
$306.52 M(+9.8%)
Dec 2018
$279.27 M(-411.3%)
$279.27 M(-12.4%)
Sep 2018
-
$318.91 M(-6.7%)
Jun 2018
-
$341.80 M(+66.3%)
Mar 2018
-
$205.48 M(-329.1%)
Dec 2017
-$89.71 M(+248.6%)
-$89.71 M
Dec 2016
-$25.73 M
-

FAQ

  • What is Kiniksa Pharmaceuticals annual stockholders equity?
  • What is the all time high annual shareholders equity for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals annual shareholders equity year-on-year change?
  • What is Kiniksa Pharmaceuticals quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals quarterly shareholders equity year-on-year change?

What is Kiniksa Pharmaceuticals annual stockholders equity?

The current annual shareholders equity of KNSA is $438.44 M

What is the all time high annual shareholders equity for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high annual stockholders equity is $438.84 M

What is Kiniksa Pharmaceuticals annual shareholders equity year-on-year change?

Over the past year, KNSA annual stockholders equity has changed by -$403.00 K (-0.09%)

What is Kiniksa Pharmaceuticals quarterly stockholders equity?

The current quarterly shareholders equity of KNSA is $438.44 M

What is the all time high quarterly shareholders equity for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high quarterly stockholders equity is $438.84 M

What is Kiniksa Pharmaceuticals quarterly shareholders equity year-on-year change?

Over the past year, KNSA quarterly stockholders equity has changed by $0.00 (0.00%)